The V Foundation Named A Charity Partner of the TCS New York City Marathon
Team V Members to Receive Free Registration, Guaranteed Entry, Celebrity Captains and More
The V Foundation for Cancer Research, one of the nation’s leading cancer research funding organizations, and ESPN are excited to announce Team V as a broadcast charity partner of the 2014 TCS New York City Marathon, to be held on November 2, 2014. Team V, The V Foundation’s official training and fundraising program, offers runners several premium incentives, including celebrity team captains, personalized fundraising support, a virtual training program and more. Net proceeds of funds raised by Team V runners will directly benefit cancer research.
“The V Foundation is honored to be a part of the 2014 TCS New York City Marathon,” said Susan Braun, CEO of The V Foundation. “As the broadcast charity partner, we can provide entry to the long sold-out race for participants, who, in turn, raise awareness and funds to defeat cancer. It’s a win all the way around!”
Embodying the late Jim Valvano’s message during his iconic 1993 ESPY Awards speech, Team V members will exemplify the “Don’t Give Up … Don’t Ever Give Up!”® spirit. By committing to raise $3,500 each for cancer research, Team V members will receive many VIP amenities, including an exclusive Team V training technical t-shirt, a race day Team V singlet, a pre-race pasta party, a Team V swag bag and an opportunity to share your “Don’t Give Up” story on ESPN. Celebrity team captains include ESPN’s SportsCenter anchors Lindsay Czarniak, John Anderson, Trey Wingo and David Lloyd; espnW columnist and on-air host Sarah Spain; co-host of ESPN’s Numbers Never Lie and First Take Jemele Hill; cancer survivor and New York Giants’ linebacker Mark Herzlich; and former United States women’s national soccer team player and current ESPN analyst Julie Foudy. The captains will provide motivational support throughout training, and are expected to mingle with Team V at the pre-race pasta party.
With a limited number of spots available, Team V offers runners the opportunity to register for the 2014 TCS New York City Marathon after the general-entry drawing has closed. The V Foundation would also like to invite previously registered participants to sign up for Team V to run this November and be reimbursed for their entry fee.
Team V members will have until December 31, 2014, to meet the $3,500 fundraising minimum with a registration cutoff of September 15. One hundred percent of the net proceeds from events will benefit The V Foundation to support cancer research. In its 21 years, The V Foundation has awarded more than $115 million in cancer research grants nationwide. The V Foundation distributes research grants for all types of cancer to the most promising scientists through a competitive process vetted by a Scientific Advisory Committee.
In its 44-year history, the TCS New York City Marathon has become the world’s biggest and most popular marathon. More than 50,000 runners finished last year’s race, the most ever in any marathon. This year’s 26.2-mile event will take place on November 2, 2014, and feature many of New York City’s notable sights along the race route.
Earlier this year, Team V raised more than $300,000 for cancer research at the inaugural Rock ‘n’ Roll Raleigh Marathon & ½ Marathon presented by WRAL benefiting The V Foundation. As Rock ‘n’ Roll Raleigh’s official charity partner, Team V will participate in the 2015 event as well. Runners and walkers across the country are welcome to join Team V and The V Foundation’s fight against cancer.
For more information about The V Foundation and to join Team V at the 2014 TCS New York City Marathon or 2015 Rock ‘n’ Roll Raleigh Marathon & ½ Marathon, please visit www.jimmyv.org.
Featured July 7th
The V Foundation’s Team V Races to Achieve Victory Over Cancer in Chicago + NYC MarathonsRead More
Featured July 6th
2021 ESPYS and Sports Humanitarian Awards to Benefit the V Foundation’s Stuart Scott FundRead More
Featured May 11th
The V Foundation and Parker Institute for Cancer Immunotherapy Announce Partnership to Co-Fund GrantsRead More